Evaluation of Inflammatory Cytokines During COVID-19

University of Vienna

Status: Unknown

Conditions: Covid19

Treatments: Diagnostic Test: Blood sample

Study type: Observational

Funder types: Other

Identifiers

NCT04824495

Version 1.1, 31.12.2021

Details and patient eligibility

About

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Full description

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Age > 18 years
• Confirmation of acute SARS-CoV2 infection
• Ability to provide informed consent

Trial design

100 participants in 1 patient group

Patients with acute COVID-19

Treatment:

Diagnostic Test: Blood sample